docs globe law logo finance medicine noctrix sleep stats Skip to content
Noctrix Health
  • Home
  • About Us
  • Press
  • Careers
  • Investor Login

Jonathan Charslesworth, PHD

By dev@noctrixhealth.com | November 13, 2020

Recent Posts

  • Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy
  • Noctrix Health Announces Enrollment of First Patient in The RESTFUL Study and Publication of Positive Pilot Study Results
  • Noctrix Health granted FDA Breakthrough Device Designation for wearable Restless Legs Syndrome Therapy
  • Noctrix Health, Inc. Completes $17M Million Series B Financing

Recent Comments

    building photo
    noctrix_logo_white

    Our Offices:
    6700 Koll Center Parkway, Suite 310
    Pleasanton, CA. 94566